Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah A Thomas

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Clinical Advances in Hematology & Oncology : H&O|April 20, 2010
Rituximab as therapy for acute lymphoblastic leukemiaDeborah A Thomas
American Anthropologist|August 25, 2020
Panic and PandemicsDeborah A Thomas
Hematology. American Society of Hematology. Education Program|November 21, 2007
Philadelphia chromosome positive acute lymphocytic leukemia: a new era of challengesDeborah A Thomas
Clinical Advances in Hematology & Oncology : H&O|June 19, 2012
Inotuzumab: the most active single agent in acute lymphoblastic leukemia?Deborah A Thomas
Clinical Advances in Hematology & Oncology : H&O|March 14, 2015
New developments in acute lymphoblastic leukemiaDan Douer, Deborah A Thomas
Hematology/Oncology Clinics of North America|September 23, 2006
Monoclonal antibody therapy for hairy cell leukemiaDeborah A Thomas, Farhad Ravandi, Hagop Kantarjian
Best Practice & Research. Clinical Haematology|March 6, 2003
New agents in the treatment of acute lymphocytic leukaemiaDeborah A Thomas, Jorge Cortes, Hagop M Kantarjian
Hematology/Oncology Clinics of North America|October 15, 2009
Monoclonal antibody therapy with rituximab for acute lymphoblastic leukemiaDeborah A Thomas, Susan O'Brien, Hagop M Kantarjian
Investigational New Drugs|June 11, 2003
Phase II study of single agent paclitaxel in adult patients with relapsed acute lymphocytic leukemiaDawn E Colburn, Deborah A Thomas, Francis J Giles
Current Hematologic Malignancy Reports|April 29, 2010
New approaches to the management of Philadelphia-chromosome-positive acute lymphocytic leukemiaDeborah A Thomas, Susan O'Brien, Jorge Cortes, et al.
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Clinical Advances in Hematology & Oncology : H&O|April 20, 2010
Rituximab as therapy for acute lymphoblastic leukemiaDeborah A Thomas
American Anthropologist|August 25, 2020
Panic and PandemicsDeborah A Thomas
Hematology. American Society of Hematology. Education Program|November 21, 2007
Philadelphia chromosome positive acute lymphocytic leukemia: a new era of challengesDeborah A Thomas
Clinical Advances in Hematology & Oncology : H&O|June 19, 2012
Inotuzumab: the most active single agent in acute lymphoblastic leukemia?Deborah A Thomas
Clinical Advances in Hematology & Oncology : H&O|March 14, 2015
New developments in acute lymphoblastic leukemiaDan Douer, Deborah A Thomas
Hematology/Oncology Clinics of North America|September 23, 2006
Monoclonal antibody therapy for hairy cell leukemiaDeborah A Thomas, Farhad Ravandi, Hagop Kantarjian
Best Practice & Research. Clinical Haematology|March 6, 2003
New agents in the treatment of acute lymphocytic leukaemiaDeborah A Thomas, Jorge Cortes, Hagop M Kantarjian
Hematology/Oncology Clinics of North America|October 15, 2009
Monoclonal antibody therapy with rituximab for acute lymphoblastic leukemiaDeborah A Thomas, Susan O'Brien, Hagop M Kantarjian
Investigational New Drugs|June 11, 2003
Phase II study of single agent paclitaxel in adult patients with relapsed acute lymphocytic leukemiaDawn E Colburn, Deborah A Thomas, Francis J Giles
Current Hematologic Malignancy Reports|April 29, 2010
New approaches to the management of Philadelphia-chromosome-positive acute lymphocytic leukemiaDeborah A Thomas, Susan O'Brien, Jorge Cortes, et al.
Pageof 11